Charles River Laboratories (CRL) to Acquire Cognate BioServices for $875 Million
Go back to Charles River Laboratories (CRL) to Acquire Cognate BioServices for $875 Million| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 183.72 +2.16 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $181.56 | 52 Week High | $89.18 | |||
| Open | $182.21 | 52 Week Low | $65.70 | |||
| Day High | $185.35 | P/E | 85.45 | |||
| Day Low | $181.53 | EPS | $2.15 | |||
| Volume | 56,166 | |||||
